Related Experiment Video
Updated: Apr 12, 2026
10:19
Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models
Published on: August 9, 2012
20.0K
Biomaterials for pelvic floor reconstructive surgery: how can we do better?
Giulia Gigliobianco1, Sabiniano Roman Regueros1, Nadir I Osman2
1Material Science Engineering, University of Sheffield, Sheffield S1 3JD, UK.
Biomed Research International
|May 16, 2015
Summary
Surgical mesh for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) shows variable outcomes. Limited inflammation and constructive remodeling correlate with better long-term success than chronic inflammation and fibrosis.
Area of Science:
- Biomedical Engineering
- Urogynecology
- Materials Science
Background:
- Stress urinary incontinence (SUI) and pelvic organ prolapse (POP) significantly affect women's quality of life.
- Surgical repair is a common treatment, often augmented with synthetic or biological materials.
- Current biomaterials for SUI and POP repair are not ideal.
Purpose of the Study:
- To review biomaterial changes and host responses after implantation for SUI and POP.
- To correlate biomaterial behavior and host response with clinical outcomes.
- To identify characteristics of successful biomaterials for pelvic floor reconstructive surgery.
Main Methods:
- Review of published animal and human studies on biomaterial implantation.
- Characterization of biomaterial degradation and host tissue reactions.
- Analysis of factors influencing surgical outcomes, including material properties and immune response.
Main Results:
- Biomaterial outcomes depend on mechanical properties, immune response, and surgical factors.
- Materials inducing limited inflammation and constructive remodeling show better long-term success.
- Chronic inflammation, fibrosis, and encapsulation are associated with poorer outcomes.
Conclusions:
- Biomaterial selection is critical for successful SUI and POP surgical repair.
- Understanding host-biomaterial interactions is key to improving long-term clinical results.
- Future biomaterials should aim to minimize adverse inflammatory responses and promote tissue integration.
